Stockreport

NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors

NKGen Biotech, Inc.  (NKGN) 
PDF SANTA ANA, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on t [Read more]